Protogenix

Ithaca, NY · Founded 2021 · Privately Held (backing)

Developer of a protein manufacturing platform designed to replace mammalian cell systems used for producing complex proteins. Protogenix is based in Ithaca, NY and was founded in 2021. Its last reported valuation was $28 million in Dec 2024. It has raised $6.8 million across 1 recorded round; the latest was a $250,000 seed round in Dec 2025.

Last reported valuation
$28.0M
Oct 2026
Priced at
—
Total raised
$6.8M
Last round
Seed Round
Dec 2025

Who backs Protogenix?

8 investors
InvestorType
SOSVVenture capital
IndieBioOther
New York VenturesVenture capital
Skull Diamond and Heart CapitalVenture capital
Center for Life Science Ventures—
Cornell University—
Grow NY—
Kevin M. McGovern Family Center for Venture Development in the Life Sciences—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Protogenix investors

8 investors are on record for Protogenix, including SOSV, IndieBio, New York Ventures and Skull Diamond and Heart Capital. The seed round in Dec 2025 drew 1 investor.

Free account
More of Protogenix with a free account
  • ·Watch Protogenix: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Protogenix. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View